Proceedings of the 2016 China Cancer Immunotherapy Workshop
Table of contents A1 Proceedings of 2016 China Cancer Immunotherapy Workshop, Beijing, China Bin Xue, Jiaqi Xu, Wenru Song, Zhimin Yang, Ke Liu, Zihai Li A2 Set the stage: fundamental immunology in forty minutes Zihai Li A3 What have we learnt from the anti-PD-1/PD-L1 therapy of advanced human cance...
Main Authors: | Bin Xue, Jiaqi Xu, Wenru Song, Zhimin Yang, Ke Liu, Zihai Li, Lieping Chen, Edward B. Garon, Siwen Hu-Lieskovan, Wei Ding, Chong-Xian Pan, Weijing Sun, Yong-Jun Liu, Lei Zheng, Delong Liu, Michel Sadelain, Cassian Yee, Rongfu Wang, Meixia Chen, Yao Wang, Zhiqiang Wu, Hanren Dai, Can Luo, Yang Liu, Chuan Tong, Yelei Guo, Qingming Yang, Weidong Han, Lisa H. Butterfield, Timothy A. Chan, Ruirong Yuan, Bo Lu, Max Ning, Harald Enzmann, Heinz Zwierzina |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-10-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://link.springer.com/article/10.1186/s13045-016-0322-x |
Similar Items
-
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
by: Jun Wang, et al.
Published: (2017-01-01) -
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
by: Zihai Li, et al.
Published: (2018-12-01) -
Novel strategies for immuno-oncology breakthroughs with cell therapy
by: Hongtao Liu, et al.
Published: (2021-07-01) -
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
by: Chongxian Pan, et al.
Published: (2020-04-01) -
Combination strategies to maximize the benefits of cancer immunotherapy
by: Shaoming Zhu, et al.
Published: (2021-09-01)